Compare Humana Inc (HUM) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs CarMax, Inc — how do they compare? Humana Inc trades at $445 (market cap $46.49B), while CarMax, Inc trades at $53.88 (market cap $7.56B). The key difference: Humana Inc is far larger — about 6.1× CarMax, Inc's market cap, and Humana Inc pays a 0.91% dividend while CarMax, Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and CarMax, Inc for 49 Days on average.
| HUM | KMX | |
|---|---|---|
Market Cap | $46.49B | $7.56B |
Volume | 2,567,704 | 3,338,522 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $64.22 |
52-Week Low | $163.67 | $30.88 |
Typical Hold Time | 53 Days | 49 Days |
Enterprise Value | $53.84B | $25.26B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
CarMax (KMX) trades at $53.28, down 3.64% amid a bearish technical signal, though recent Q2 2027 earnings beat estimates with EPS of $1.16 versus $0.732 expected. The company reported 19.5% revenue growth to $7.9 billion, driven by strong unit sales and cost control. Analyst consensus is mixed with 29.73% buy ratings and a $58.89 price target, while technical indicators show support at $52-$53 and resistance at $54.
The outlook is cautiously optimistic as CarMax's turnaround strategy shows early traction, but high debt levels and thin net margins near 1% pose risks. Near-term catalysts include the November strategic update, though macroeconomic pressures on consumer spending could challenge sustained growth. The stock offers value with a P/S of 0.28, but investors should monitor execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
